✦ LIBER ✦

Successful use of risperidone after neuroleptic malignant syndrome (NMS): a 1-year follow-up

✍ Scribed by Ashok N. Singh; David M. Hambidge

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 69 KB
Volume: 13
Category: Article
ISSN: 0885-6222
DOI: 10.1002/(sici)1099-1077(199801)13:1<65::aid-hup934>3.0.co;2-q

No coin nor oath required. For personal study only.

✦ Synopsis

Successful use of risperidone after neuroleptic malignant syndrome (NMS): a 1-year follow-up Neuroleptic malignant syndrome (NMS) is a rare and an acute life-threatening reaction that can occur in patients on neuroleptic medication. Few authors have addressed the issue of re-challenge in previous NMS and further pharmacological approach to psychotic patients with a history of NMS is controversial. We report the case of a patient who responded well to risperidone, an atypical antipsychotic agent after developing NMS on receiving conventional antipsychotic agents.